Method of enhancing absorptions of transmucosal administration formulations
US8012503B2 · kind B2 · utility
5Cited by
4References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 21, 2008 |
| Grant date | Sep 6, 2011 |
| Priority date | — |
| Expiry date | Jan 21, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for enhancing absorption of a compound in a medicament that is suitable for administering transmucosally to a subject is conducted in an environment having a suitable pH. The suitable pH is determined based on the ionization constant (dissociation constant) of the compound in water, the solubility of the ionized form of the compound, and the solubility of the non-ionized form of the compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.